Congenital myopathy-4A (CMYO4A) is an autosomal dominant disorder of the skeletal muscle characterized by the onset of muscle weakness in infancy or childhood. The severity and pattern of muscle weakness varies, but most affected individuals show mildly delayed motor development, hypotonia, generalized muscle weakness, and weakness of the proximal limb muscles and neck muscles, resulting in difficulty running and easy fatigability. Many patients have respiratory insufficiency with reduced vital capacity, sometimes requiring noninvasive ventilatory assistance. Other common features include myopathic facies, high-arched palate, myasthenia, scapular winging, and scoliosis. Histologic findings on skeletal muscle biopsy are variable, even in patients with the same mutation. Muscle fibers can contain nemaline rod inclusions, subsarcolemmal 'cap' structures, and fiber-type disproportion (Clarke et al., 2008; Waddell et al., 2010; Malfatti et al., 2013).
For a discussion of genetic heterogeneity of congenital myopathy, see CMYO1A (117000).
For a discussion of genetic heterogeneity of nemaline myopathy, see 256030. [from OMIM]
Also known as: CAPM1, CFTD, CMYO4A, CMYO4B, CMYP4A, CMYP4B, HEL-189, HEL-S-82p, NEM1, OK/SW-cl.5, TM-5, TM3, TM30, TM30nm, TM5, TPM3nu, TPMsk3, TRK, hscp30, TPM3
Summary: tropomyosin 3
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.